A-Rod Could Get an MLB Suspension This Week

The MLB will announce the suspensions of Alex Rodriguez, and eight other baseball players, by the end of the week for their alleged involvement in a performance-enhancing drug scheme, according to the Daily News's sources.

This article is from the archive of our partner .

The MLB will announce the suspensions of Alex Rodriguez, and eight other baseball players, by the end of the week for their alleged involvement in a performance-enhancing drug scheme, according to the Daily News's sources. Rodriguez, for his part, has already said he'll appeal whatever repercussions are thrown his way.

The league is reportedly considering a lifetime ban against Rodriguez, who might face punishment for allegedly misleading the MLB during their investigation into the Biogenesis clinic (if you need a refresher on the months-long Biogenesis scandal, we've got you covered). Ryan Braun is already suspended for the rest of the season for his involvement with the clinic. On Tuesday, the MLB spoke to union reps at a Players Association meeting, during which they outlined their plans to dole out punishment in the investigation. The Daily News explains:

Most of the players will be suspended for 50 games, but some – including the Yankees’ embattled superstar – face stiffer penalties for lying to MLB investigators or interfering in baseball’s year-long Biogenesis investigation. Not all of the players linked in media reports to Biogenesis face discipline, sources have told The News. Two former Yankees - Toronto Blue Jays outfielder Melky Cabrera and Oakland A’s pitcher Bartolo Colon – will not be punished because they already have been suspended as a result of their links to Biogenesis and its owner, self-styled “biochemist” Anthony Bosch.

A-Rod, 38, missed last season due to a hip injury. Facing suspensions (which the MLB seems determined to see through), and at the very least a drawn-out appeal process, some are questioning whether he'll ever play a major league game again.

This article is from the archive of our partner The Wire.